Absolute lymphocyte count predicts overall survival in follicular lymphomas.
about
Cutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementAbsolute lymphocyte count and risk of short-term infection in patients with immune thrombocytopenia.Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.Absolute lymphocyte count as a predictor of mortality in emergency department patients with paraquat poisoningAbsolute monocyte and lymphocyte count prognostic score for patients with gastric cancerImmunosuppression in patients with high-grade gliomas treated with radiation and temozolomideLocalization, expression change in PRRSV infection and association analysis of the porcine TAP1 genePretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantationAdoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphomaAnalysis of prognostic factors in lymphoma patients with bone marrow involvement: a single center cohort study.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cellsPrognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaB7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: a meta-analysis.Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Murine rhabdomyosarcoma is immunogenic and responsive to T-cell-based immunotherapy.Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma.FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils.Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas.Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.Predictors of Chemotherapy Related Toxicities in Elderly Lymphoma Patients: Experience from a Tertiary Cancer Centre.Unmet needs in the first-line treatment of follicular lymphoma.Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.Clinical characteristics and prognostic factors in Chinese patients with Hodgkin's lymphoma.The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
P2860
Q27024076-4935263C-CB03-48CD-94AF-1376048A67D8Q33412766-8EEC2ACD-D1FA-45B1-BEA9-DD28FBDBF23EQ34294166-328B6D18-2FDB-4A50-96F2-2751A633B513Q35036140-51A2720B-6783-4B09-9061-BC10A3F23D08Q35152328-08E55C81-1AE7-4F95-AE67-5AEF2A2EC5E8Q35167257-36813656-12E1-4DC8-9A64-0D9B5001DBE6Q35578741-E848054C-4AB8-4DBD-8058-73D8B00DED0AQ35671545-457CD89E-8897-4305-B9D6-9B8C67F3143CQ35752854-FE2165B5-F2C7-4612-80DA-361174A7857AQ35791247-1190F66D-DDD5-4BFB-BF4B-BEB6833909FCQ35921894-4C42C14B-C773-4F9D-80EC-690B4BCEC7ECQ35959252-6094A23D-47A8-41F3-95A5-14FA4AED3EC6Q36470196-BDA2E3E4-D731-42C9-AB1F-C689CBD5DD7FQ36649570-9770D29C-7407-4F77-9A32-3C4077FFF90FQ37343931-AEA0086A-2839-4701-B0A7-E121827702F5Q37348263-FF5ABBE4-1B3A-4916-A960-D51C8CB35E9EQ37395913-7635A6F8-9E09-4DD5-8368-8F8295A96776Q37685586-186A38D3-5FC7-4175-AD16-11ABA2CCC0D7Q37944565-F3E8587A-D70F-4BE3-AE51-10A5F16F9379Q37972096-9D3E9ECC-9EB6-43FF-BC9A-6718F4D2A7E7Q38812270-8E9DFD45-0C83-4258-ACBF-E7CDBD25C133Q38912265-AF7539B8-3028-49AE-B1FC-B71B7CB6242FQ39564978-C36778CE-62F6-4CBC-BB68-5624D3C01B6EQ39624030-93C73FC6-F0C5-4FDA-96EF-932597758586Q40551125-32CDAF3B-6034-4925-85FA-11E969C84775Q41008736-FF68A28B-9E77-4B1F-BF0E-6A52176187E1Q41148150-BFE19FA6-CD46-437A-AFCD-2D9049DFC89DQ41513921-D9994B4A-2429-4F74-994B-F5C3AAB0DC52Q41996270-5D24A0C0-3470-4770-9E02-16E48B622F13Q42380313-E10ED578-2ECA-49C4-AD9F-38A9461762EBQ42584382-AEB69F50-B67C-44EC-95B3-5A1A4701C029Q42591459-14A9A8A2-C446-4E68-9FFB-4504E64E2251Q44575965-A5E58BF9-2B24-4EBC-878C-ED31AF9ACCFEQ46660874-D06A5789-1CB7-4347-BC4F-E0A245E7BBFDQ48034709-8C50E323-85D6-469B-9F7F-C430D5D49072Q50092825-AAE065AE-35EF-4C23-9157-BAF8F87DE0EAQ50710717-15FB72E3-EF10-49C0-9A38-07398841C590Q50922836-6A5328FF-D404-47C3-BC50-6D4A547F864BQ51050643-4AE50318-DC44-4AC6-B487-5D5B8F424358Q51568489-126A9BF8-DD87-4479-B5BA-D2D8256CA821
P2860
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@en
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@nl
type
label
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@en
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@nl
prefLabel
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@en
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@nl
P2093
P2860
P1476
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
@en
P2093
David J Inwards
Ivana N Micallef
Joseph P Colgan
Kay Ristow
Luis F Porrata
Mustaqeem Siddiqui
Patrick B Johnston
Stephen M Ansell
Svetomir N Markovic
Thomas E Witzig
P2860
P304
P356
10.1111/J.1365-2141.2006.06232.X
P407
P577
2006-08-01T00:00:00Z